|
Interleukin Genetics, Inc. (Interleukin) is a genetics-focused personalized health company engaged in the research, development, manufacture and sale of DNA based risk assessment tests for the personalized health markets. It developed a DNA based risk assessment test to identify whether or not individuals have a genetic risk factor. The company markets a line of genetic tests. Under the Inherent Health brand the company provides tests for Bone Health, Weight Management, Heart Health and Nutritional Needs; and under the Genetic Test Pipeline the company provides tests for Obesity Management, Osteoarthritis, Periodontal Disease and Other proprietary consumer focused genetic tests. The company products are distributed through sales partners and its own sales channels. It operates in Europe and the US. Interleukin is headquartered in Waltham, the US. ( http://www.companyprofilesandconferences.com/report/Interleukin-Genetics-Inc-ILIU-Product-Pipeline-Analysis.html ) This report is a source for data, analysis and actionable intelligence on the Interleukin Genetics, Inc. portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date. Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts. Scope - Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments. - Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase. - Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date. - Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application. - Data on relevant clinical trials and product patent details, wherever applicable. - Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility. For more information kindly visit : http://www.companyprofilesandconferences.com/report/Interleukin-Genetics-Inc-ILIU-Product-Pipeline-Analysis.html Or Contact us at : Company Profiles and Conferences Flat A-1901/02, 19th floor, Kshitij Building,Sec-19, Palm Beach Road, Sanpada, Navi Mumbai - 400705, India. Phone : +91 22 2756 1536 Fax : +91 22 2757 9131 E-mail : info@companyprofilesandconferences.com Website : www.companyprofilesandconferences.com
Related Articles -
Company Pofiles, Interleukin Genetics, ILIU, Company Profile,
|
